Soft Tissue Sarcoma Adult research hub

Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas

This study is looking at a new combination of two drugs, pembrolizumab and cabozantinib, for people with advanced sarcomas. The aim is to see if this combination can help shrink tumours or slow their growth in three types of sarcoma.